The company is only selling about $1k of product per month - that's only about 10-11 bottles (30 ml each) of pure CBD oil (priced at $95/bottle).
What they theoretically "could" sell (even at a higher margin) is NOWHERE near what their current results show. The optimistic view is that even at a 100x improvement on sales, the net revenue after Syd's royalty cut, G&A expenses, new employee overheads, interest expense, etc....we are still WAY underwater here.
Just to produce the inventory and pay employees, marketing, cost of goods, etc....they will have to tap into that "unlimited" authorized shares to make good on growing the business.
A simple question for you - Sydney has so far been able to attain $8.1 million dollars in additional-paid-in-capital thru issuing shares/convertible notes - what exactly have shareholders received in value anywhere near this amount??